SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
RiceBran Technologies (RIBT) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 19/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RIBT
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.28
Book Value / Share$0.00
Revenue / Share$3.24
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-39.64 |
$40.11M |
$-23.03M |
-57.4% |
| 2015 |
$-9.00 |
$39.9M |
$-8.27M |
-20.7% |
| 2016 |
$-9.13 |
$39.41M |
$-8.53M |
-21.6% |
| 2017 |
$-3.80 |
$13.36M |
$-4.53M |
-33.9% |
| 2018 |
$-3.67 |
$14.76M |
$-8.1M |
-54.9% |
| 2019 |
$-4.59 |
$23.71M |
$-14.87M |
-62.7% |
| 2020 |
$-2.85 |
$26.2M |
$-11.73M |
-44.8% |
| 2021 |
$-1.87 |
$31.13M |
$-8.95M |
-28.7% |
| 2022 |
$-1.42 |
$41.62M |
$-7.86M |
-18.9% |
| 2023 |
$-1.28 |
$22.65M |
$-8.98M |
-39.6% |
